rhodioloside has been researched along with pentylenetetrazole in 1 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (pentylenetetrazole) | Trials (pentylenetetrazole) | Recent Studies (post-2010) (pentylenetetrazole) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 6,737 | 30 | 1,496 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, T; Wang, W; Wang, Y; Wu, Y | 1 |
1 other study(ies) available for rhodioloside and pentylenetetrazole
| Article | Year |
|---|---|
Salidroside shows anticonvulsant and neuroprotective effects by activating the Nrf2-ARE pathway in a pentylenetetrazol-kindling epileptic model.
Topics: Animals; Anticonvulsants; Carboxylic Ester Hydrolases; Epilepsy; Glucosides; Hippocampus; Kindling, Neurologic; Male; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Pentylenetetrazole; Phenols; Rats; Rats, Wistar; Signal Transduction | 2020 |